乐心医疗
(300562)
| 流通市值：22.54亿 | | | 总市值：30.39亿 |
| 流通股本：1.62亿 | | | 总股本：2.19亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 757,129,146.52 | 521,364,786.34 | 273,307,188.91 | 983,982,436.12 |
| 营业收入 | 757,129,146.52 | 521,364,786.34 | 273,307,188.91 | 983,982,436.12 |
| 二、营业总成本 | 685,490,345.42 | 470,355,356.57 | 246,632,304.47 | 908,152,076.03 |
| 营业成本 | 487,684,162.71 | 338,865,245.07 | 171,149,117.44 | 638,873,788.26 |
| 税金及附加 | 5,270,907 | 3,976,047.66 | 1,960,770.95 | 7,875,594.37 |
| 销售费用 | 62,173,571.68 | 42,311,401.59 | 26,880,221.09 | 93,808,201.62 |
| 管理费用 | 58,034,995.18 | 36,329,402.08 | 22,739,145.77 | 88,443,748.31 |
| 研发费用 | 70,314,459.02 | 49,957,539.37 | 26,345,008.64 | 96,807,528.07 |
| 财务费用 | 2,012,249.83 | -1,084,279.2 | -2,441,959.42 | -17,656,784.6 |
| 其中:利息费用 | 3,002,999.71 | 1,598,440.73 | 819,716.08 | 5,346,679.63 |
| 其中:利息收入 | 4,886,259.94 | 2,703,077.82 | 781,204.57 | 7,349,831.58 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -137,329.82 | 194,305.79 | 1,306,601.23 | -136,535.03 |
| 加:投资收益 | 4,331,584.38 | 3,123,644.26 | -702,911.05 | 302,371.39 |
| 资产处置收益 | -2,769.11 | -150,131.33 | 49,062.26 | 90,332.76 |
| 资产减值损失(新) | -5,755,914.8 | -5,714,429.83 | - | -19,326,754.33 |
| 信用减值损失(新) | -4,969,898.63 | -5,939,668.22 | -3,935,111.3 | -1,216,344.28 |
| 其他收益 | 3,321,716.79 | 1,555,731.01 | 665,150.22 | 2,877,223.94 |
| 四、营业利润 | 68,426,189.91 | 44,078,881.45 | 24,057,675.8 | 58,420,654.54 |
| 加:营业外收入 | 144,782.49 | 109,459.32 | 2,001.7 | 2,148,817.81 |
| 减:营业外支出 | 816,197.34 | 62,951.95 | 52,374.44 | 530,001.04 |
| 五、利润总额 | 67,754,775.06 | 44,125,388.82 | 24,007,303.06 | 60,039,471.31 |
| 减:所得税费用 | 2,992,615.73 | 2,874,102.54 | 1,221,307.27 | 1,883,240.86 |
| 六、净利润 | 64,762,159.33 | 41,251,286.28 | 22,785,995.79 | 58,156,230.45 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 64,762,159.33 | 41,251,286.28 | 22,785,995.79 | 58,156,230.45 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 65,681,388.28 | 42,290,430.52 | 22,942,005.96 | 61,364,226.27 |
| 少数股东损益 | -919,228.95 | -1,039,144.24 | -156,010.17 | -3,207,995.82 |
| 扣除非经常损益后的净利润 | 59,617,527.59 | 38,070,928.81 | 20,648,884.66 | 55,977,498.26 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.3 | 0.19 | 0.11 | 0.28 |
| (二)稀释每股收益 | 0.3 | 0.19 | 0.11 | 0.28 |
| 八、其他综合收益 | -723,961.64 | -812,328.02 | -641.48 | -54,794,563.4 |
| 归属于母公司股东的其他综合收益 | -723,961.64 | -812,328.02 | -641.48 | -54,794,563.4 |
| 九、综合收益总额 | 64,038,197.69 | 40,438,958.26 | 22,785,354.31 | 3,361,667.05 |
| 归属于母公司股东的综合收益总额 | 64,957,426.64 | 41,478,102.5 | 22,941,364.48 | 6,569,662.87 |
| 归属于少数股东的综合收益总额 | -919,228.95 | -1,039,144.24 | -156,010.17 | -3,207,995.82 |
| 公告日期 | 2025-10-28 | 2025-08-16 | 2025-04-26 | 2025-03-29 |
| 审计意见(境内) | | | | 标准无保留意见 |